Patent ID: 11911381
Assignee: SUMITOMO PHARMA CO. LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 8:
9. The compound of claim 7, wherein the crystal form is characterized by a powder x-ray diffraction pattern having diffraction angle (2θ°) peaks of 4.3°±0.2°, 7.0±0.2°, 9.9°±0.2°, 10.6°±0.2°, 11.8°±0.2°, 15.2°±0.2°, 15.5°±0.2°, 15.9°±0.2°, 16.5°±0.2°, 16.8°±0.2°, and 17.9°±0.2°.